Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th January 2023
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WSAVA launches essential medicines list audit
“The WSAVA List of Essential Medicines for Cats and Dogs has proved an important step forward in our efforts to improve global drug availability" - Dr Paulo Steagall.
The review comes ahead of a revised version later this year. 

Vets and industry stakeholders are being invited to submit their comments on the current edition of the WSAVA List of Essential Medicines for Cats and Dogs. 

The open audit commences Monday, 9 January prior to an expected revised version of the list later this year.

Launched in 2020, the document was developed by the WSAVA's Therapeutics Guidelines Group to address the global challenges faced by companion animal vets in accessing vital veterinary medicines.

The topic was addressed during the recent ‘Shaping the Future’ session at WSAVA World Congress 2022 in Lima, Peru. A stakeholder meeting was also held during the Congress to discuss the issue in more detail and to explore potential solutions. 

Dr Paulo Steagall, co-chair of the Therapeutics Guidelines Group, said: “The WSAVA List of Essential Medicines for Cats and Dogs has proved an important step forward in our efforts to improve global drug availability. We know that it is already supporting regulatory decision-making around licensing, registration and approval, as well as assisting with pharmacovigilance. 

“As it was launched in 2020, it is now time for its three-yearly review and, for this, we are calling on the global veterinary community to help us so that we can ensure that the document fulfils its purpose of becoming a key element of the regulatory framework and a useful tool to ensure access to veterinary medicines globally. 

“We are keen to hear from veterinarians, from industry and from all other stakeholders with their suggestions and comments as to what the core and complementary medicines for treating the most frequent and important diseases in small animal companion medicine should be. This will ensure that the 2023 edition of the WSAVA Essential Medicines List for Cats and Dogs is fully up-to-date when we release it later in the year.” 

The document is available for free on the WSAVA website, including core and complementary essential medicines, listed alphabetically, either by drug category or organ system/specialty. 

Submissions should be sent to the WSAVA Therapeutics Guidelines Group at wsavatgg@gmail.com by 31 March 2023. 

Become a member or log in to add this story to your CPD history

Webinar to explore history of KC breed registers

News Story 1
 A free webinar exploring the development of the Kennel Club's registration system and the evolution of closed breed registers has been announced.

Hosted by Dr Alison Skipper, veterinary and research advisor at the Kennel Club, the webinar will delve into the development of the registry and how the changing landscape of scientific knowledge has shaped breeding practices. It will also look at what this means for the future of pedigree dogs.

The session will culminate with a look at The Kennel Club's ongoing and future engagement in this area, with a chance for attendees to put forward their thoughts and questions for discussion.

This event takes place on Microsoft Teams on Tuesday, 10 June at 7pm. To learn more, visit events.teams.microsoft.com  

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.